Division of Cardiovascular Medicine
Our department offers comprehensive, high-quality heart care to patients, whether they need treatment for a common condition or one that requires advanced procedures and technology.
Our team-based approach to patient care brings together specialists from cardiovascular medicine, pediatric cardiology, thoracic and vascular surgery, and interventional radiology.
Our programs provide training of the highest caliber, in order to prepare clinicians and researchers who will serve as leaders in academic cardiovascular medicine. We work collaboratively with faculty from many disciplines and departments in the School of Medicine, and fellows have access to highly trained physicians and staff who are deeply committed to patient care.
Chief of cardiac electrophysiology Dr. Pamela Mason is featured in segment discussing atrial fibrillation.Learn MoreAtrial fibrillation is a heart rhythm disorder that causes the pulse to be too fast and irregular. Risk factors can include high blood pressure, diabetes, and sleep apnea. There can also be an increased risk of stroke due to restricted blood flow to the upper chambers of the heart.
Dr. John Saxon is featured in weekly segment discussing heart valve disease.Learn MoreIt’s important to recognize the early signs of heart valve disease, such as shortness of breath. Because the disease has a progressive nature, the earlier treatment is started, the better the outcome. In addition to caring for patients, UVA is currently enrolling in over 20 clinical trials evaluating devices or treatment strategies for valve disease.
New Technology at UVA Health Offers Safer Treatment For Atrial FibrillationLearn MoreThe University of Virginia Health System is adopting a newer technology that’s changing how doctors treat atrial fibrillation, offering patients what physicians describe as a safer and more precise option. “What’s been shown is that it’s more efficient and it’s safer for patients,” said Dr. Mike Mangrum. “Over the last two years, at least half of all AFib ablations in the country are now being done with pulse field ablation, and that number continues to grow.”
Driving Change for Generations to Come: UVA Health’s First Cardiovascular Disease in Women Symposium
On Nov. 1, 2025, UVA Health hosted its inaugural Cardiovascular Disease in Women Symposium, designed to reshape how cardiovascular disease in women is studied, diagnosed, and treated. Led by Patricia Rodriguez-Lozano, MD, MS, Director, UVA Health Women’s Heart Program — the event brought together national leaders, UVA Health and UVA experts, trainees, and patients for a day of learning, inspiratio
Support Our Mission
Research holds enormous promise for bringing innovative strategies to the diagnosis and treatment of cardiovascular disease. UVA physicians and scientists are seeking a better understanding of the cellular and genetic underpinnings of cardiovascular disease, while actively participating in clinical trials to evaluate new treatments.